Both in Pharmaceuticals
Oric Pharmaceuticals vs Jade Biosciences
Over the past year ORIC returned −27.2% and JBIO returned +48.5%; their daily moves had a correlation of 0.11.
ORIC −27.2% JBIO +48.5%Growth of $1, one year, split-adjusted
| Metric | ORIC | JBIO |
|---|---|---|
| Price | $9.24 | $14.06 |
| Market cap | $957.8M | $894.2M |
| Today | +2.78% | −1.26% |
| 1 month | −26.2% | +2.1% |
| 6 months | −5.4% | −42.0% |
| Year to date | +13.0% | −8.9% |
| 1 year | −28.5% | +48.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $264.8M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 93.5% | 51.4% |
| Short % of float | 25.5% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).